Eli Lilly Sales rebates and discounts increased by 0.9% to $17.55B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 51.9%, from $11.55B to $17.55B. Over 5 years (FY 2020 to FY 2025), Sales rebates and discounts shows an upward trend with a 24.3% CAGR.
current_liabilities_sales_rebates_and_discounts| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $7.04B | $7.19B | $6.85B | $6.77B | $7.99B | $8.57B | $8.78B | $9.53B | $10.39B | $11.52B | $11.69B | $9.43B | $12.45B | $12.43B | $11.54B | $11.55B | $14.54B | $17.62B | $17.38B | $17.55B |
| QoQ Change | — | +2.1% | -4.7% | -1.1% | +18.1% | +7.2% | +2.5% | +8.5% | +9.0% | +10.9% | +1.4% | -19.3% | +32.0% | -0.1% | -7.2% | +0.1% | +25.9% | +21.2% | -1.4% | +0.9% |
| YoY Change | — | — | — | — | +13.6% | +19.2% | +28.3% | +40.8% | +30.0% | +34.5% | +33.1% | -1.0% | +19.8% | +7.9% | -1.3% | +22.5% | +16.8% | +41.8% | +50.6% | +51.9% |